| Dr Leo D Verlander, MD | |
|
1214 Coolidge Blvd, Lafayette, LA 70503-2621 | |
| (337) 261-5151 | |
| Not Available |
| Full Name | Dr Leo D Verlander |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 45 Years |
| Location | 1214 Coolidge Blvd, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134116171 | NPI | - | NPPES |
| 1332577 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 015226 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lafayette General Medical Center | Lafayette, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lafayette Health Ventures Inc | 9335043074 | 216 |
News Archive
Can-Fite BioPharma Ltd, a biopharmaceutical company, traded on the TASE and developing anti- inflammatory and anti-cancer drugs, announced today the filing of a patent application, in conjunction with the United Stated National Institutes of Health (NIH), for the treatment of Uveitis with its A3 adenosine receptor ligands.
LPBP Inc. announces that the board of directors has declared a final distribution in the aggregate amount of approximately $2.8million, or $0.0099 per share, to holders of the Company's Class A Common Shares and $0.009869 per share to holders of the Class B Non-Voting Shares payable on October 29, 2009.
Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.
Cardiovascular disease has a particularly large impact on life expectancy if patients also have bipolar disorder, say researchers.
For the fifth consecutive year, Standard Register is being honored by the Premier health alliance with its Supplier Performance Award at the 2010 Premier Annual Breakthroughs Conference and Exhibition in Washington D.C. The award ceremony is being held at the Gaylord National Hotel and Convention Center today, June 9.
› Verified 8 days ago
| Entity Name | Lafayette Health Ventures Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417986092 PECOS PAC ID: 9335043074 Enrollment ID: O20041105000263 |
News Archive
Can-Fite BioPharma Ltd, a biopharmaceutical company, traded on the TASE and developing anti- inflammatory and anti-cancer drugs, announced today the filing of a patent application, in conjunction with the United Stated National Institutes of Health (NIH), for the treatment of Uveitis with its A3 adenosine receptor ligands.
LPBP Inc. announces that the board of directors has declared a final distribution in the aggregate amount of approximately $2.8million, or $0.0099 per share, to holders of the Company's Class A Common Shares and $0.009869 per share to holders of the Class B Non-Voting Shares payable on October 29, 2009.
Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.
Cardiovascular disease has a particularly large impact on life expectancy if patients also have bipolar disorder, say researchers.
For the fifth consecutive year, Standard Register is being honored by the Premier health alliance with its Supplier Performance Award at the 2010 Premier Annual Breakthroughs Conference and Exhibition in Washington D.C. The award ceremony is being held at the Gaylord National Hotel and Convention Center today, June 9.
› Verified 8 days ago
| Entity Name | Lafayette General Endoscopy Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376828202 PECOS PAC ID: 9335162486 Enrollment ID: O20111017000062 |
News Archive
Can-Fite BioPharma Ltd, a biopharmaceutical company, traded on the TASE and developing anti- inflammatory and anti-cancer drugs, announced today the filing of a patent application, in conjunction with the United Stated National Institutes of Health (NIH), for the treatment of Uveitis with its A3 adenosine receptor ligands.
LPBP Inc. announces that the board of directors has declared a final distribution in the aggregate amount of approximately $2.8million, or $0.0099 per share, to holders of the Company's Class A Common Shares and $0.009869 per share to holders of the Class B Non-Voting Shares payable on October 29, 2009.
Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.
Cardiovascular disease has a particularly large impact on life expectancy if patients also have bipolar disorder, say researchers.
For the fifth consecutive year, Standard Register is being honored by the Premier health alliance with its Supplier Performance Award at the 2010 Premier Annual Breakthroughs Conference and Exhibition in Washington D.C. The award ceremony is being held at the Gaylord National Hotel and Convention Center today, June 9.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leo D Verlander, MD Po Box 53847, Lafayette, LA 70505-3847 Ph: (337) 261-5151 | Dr Leo D Verlander, MD 1214 Coolidge Blvd, Lafayette, LA 70503-2621 Ph: (337) 261-5151 |
News Archive
Can-Fite BioPharma Ltd, a biopharmaceutical company, traded on the TASE and developing anti- inflammatory and anti-cancer drugs, announced today the filing of a patent application, in conjunction with the United Stated National Institutes of Health (NIH), for the treatment of Uveitis with its A3 adenosine receptor ligands.
LPBP Inc. announces that the board of directors has declared a final distribution in the aggregate amount of approximately $2.8million, or $0.0099 per share, to holders of the Company's Class A Common Shares and $0.009869 per share to holders of the Class B Non-Voting Shares payable on October 29, 2009.
Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.
Cardiovascular disease has a particularly large impact on life expectancy if patients also have bipolar disorder, say researchers.
For the fifth consecutive year, Standard Register is being honored by the Premier health alliance with its Supplier Performance Award at the 2010 Premier Annual Breakthroughs Conference and Exhibition in Washington D.C. The award ceremony is being held at the Gaylord National Hotel and Convention Center today, June 9.
› Verified 8 days ago
Dr. Gregory Elmore Verlander, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 610 Girard Park Dr, Lafayette, LA 70503 Phone: 337-233-4463 | |
Steven K Staires, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 208, Lafayette, LA 70508 Phone: 337-234-3757 Fax: 337-234-3733 | |
Deborah H Kennedy, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1214 Coolidge Blvd, Lafayette, LA 70503 Phone: 337-706-1500 Fax: 337-769-7164 | |
Dr. Maria Del Carmen Sanchez, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1211 Coolidge Blvd, Suite 302, Lafayette, LA 70503 Phone: 337-269-6062 | |
Dr. Amarendar Kasarla, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-988-4298 | |
Leopold D Landry Jr., MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1101 S College Rd, Suite 100, Lafayette, LA 70503 Phone: 337-233-8603 Fax: 337-234-0341 |